Jake Shortt

Haematologist and research scientist @MonashHealth & @SCSMonash - views are my own

[Australasian Leukaemia & Lymphoma Group (ALLG) @ALLGtrials]

ALLG member-doctors have delivered a striking letter to the New Zealand Prime Minister pointing out the stark reality of worse outcomes for Kiwis with blood cancer. This letter proposes immediate actions to address this unmet need - https://t.co/DFkrdeUnek.

[Jake Shortt @JakeShortt3]

Celebrating the 10th birthday of the Blood Cancer Therapeutics lab with the team, alumni and friends. Thanks to all that have helped make the job fun and rewarding for a whole decade ⁦⁦@SCSMonash⁩. Awesome spring day at Oakleigh bowling club for it!

[Blood Journals Portfolio @BloodPortfolio]

T-cell dysregulation identified on tissue, blood, and CD8 PET imaging is potentially associated with response to immunotherapy. https://t.co/L8VIbXFFYW #clinicaltrialsandobservations #immunobiologyandimmunotherapy #lymphoidneoplasia

[Robert Z. Orlowski @Myeloma_Doc]

#Myeloma Paper of the Day: DCAF1 (aka Vpr-binding protein; VPRBP) is essential for myeloma survival & analogues of B32B3, a previously disclosed inhibitor, show enhanced potency as microtubular destabilizing agents w/ kinase independent properties: https://t.co/yIKbKatu3T. #mmsm

[Jake Shortt @JakeShortt3]

Great to catch up with our consumer advisor and long time supporter of the Blood Cancer Therapeutics lab to discuss our ⁦@DalgleishCentre⁩ myeloma project this week

[Jake Shortt @JakeShortt3]

I couldn’t be more proud to be part of the ⁦@MonashHealth⁩ Haematology team ⁦today ⁦@RunMelbourne⁩. Thanks to family members, path lab, trials, nurses, docs, pharmacy and ICU for helping raise $15k for our patients.

[Monash University School of Clinical Sciences @SCSMonash]

A national first for rare disease research.
Australia’s new bone marrow failure biobank has launched at @MonashUni, powered by @MaddiesVision.
Led by @SCSMonash + @Monash_SPHPM, the AMFB brings data + samples together to fuel discovery.
🔗 Read full story: https://t.co/6ifBBcCiGd
📩Get in touch: [email protected]
#RareDisease #BMFS #Biobanking #MonashResearch

[Jake Shortt @JakeShortt3]

@paulbeavis4 @Nature Congratulations Paul, Phil and team. Amazing work!

[Jake Shortt @JakeShortt3]

We are going bigger and better this year in Team Monash Haematology. Please support us as we raise funds for our patients with blood diseases. I can guarantee every dollar makes a big difference to our efforts in the clinic and on the wards.
https://t.co/sPAT2n1HNF

[Jake Shortt @JakeShortt3]

Haematology @MonashHealth and @SCSMonash publishing our ‘first 50’ intensive AML inductions with real world outcomes exceeding that of comparative trials (91% cCR) - thanks to the entire team, esp. our nurses on ward 44. https://t.co/ph73uP8q78

[Jake Shortt @JakeShortt3]

Fantastic to host the ⁦@MonashHealth⁩ ⁦@SCSMonash⁩ Haematology Research retreat in stunning Healesville this weekend. Special thanks to guest speakers ⁦@JaneOliaro⁩ and ⁦@markrdowling⁩ ⁦@PeterMacCC⁩ for their excellent contributions

[Jake Shortt @JakeShortt3]

Congratulations to Dr Trung Ngo, awarded the inaugural Sukanya Roy Prize in Haematopathology at the ⁦@MonashHealth⁩ Haematology Research retreat

[Australasian Leukaemia & Lymphoma Group (ALLG) @ALLGtrials]

On World Cancer Day, ALLG researcher Dr Chyn Chua spoke to the ALLG team about our world-first AMLM26 INTERCEPT trial & how it offers molecularly targeted therapies via an innovative multiple adaptive arm design to address unique needs of AML patients - https://t.co/HwP87B4c7y

[Jake Shortt @JakeShortt3]

We are on the hunt for a new high grade lymphoma lead @MonashHealth. Please share this exciting opportunity to join our world class team with your colleagues or let me know if you’re interested!

https://t.co/3tVYJj1moW

[Jake Shortt @JakeShortt3]

@AzadOncology @UniMelb @melkauf2018 @PeterMacCC @pros_tic @ANZUPtrials @COSAoncology @neerajaiims @EdmondMKwan @PCFnews @DrMHofman @gu_onc @_ShankarSiva Congrats from your old ‘brother in arms’ from the good old days in the MHTP

[Jake Shortt @JakeShortt3]

Great work from Paul Yeh and team in the molecular lab ⁦@MonashHealth⁩ getting this assay up and accredited. Already seeing some very interesting diagnoses that may otherwise have remained cryptic https://t.co/aaFleaZTu5

[Jake Shortt @JakeShortt3]

@Farehlab @ScienceAdvances @C_Shembrey Very clever science from Mo et al!

[Fareh Mohamed @Farehlab]

Very excited to share our paper published today in @ScienceAdvances. We describe design principles of Cas13 to silence oncogenic SNVs (e.g KRAS) with single-base precision. Fantastic collaboration led by the amazing postdoc @C_Shembrey.
https://t.co/RSrIeUPldG

[Atul Malhotra @Atul_Monash]

Super proud of my @Neo_CellTherapy team on this landmark CORD-Safe publication out in @eBioMedicine led by @LindsayDZhou moving the field forward.
https://t.co/z7Igda25Xp

#neoEBM @EBNEO @ESPR_ESN @nicupodcast

Watch out for the cord-cell RCT !

[Women in Lymphoma - [email protected] @WomenInLymphoma]

⚕️ @WomenInLymphoma Steering Committee members, advocates, sponsors and supporters from all over the world🌍networking and sharing connections, initiatives and experience at #ASH24
#lymsm #lymphoma @ASH_hematology